PROS1 and COVID-19: Antibody profiles against the S protein have been studied in patients with COVID-19 and individuals vaccinated with either inactivated SARS-CoV-2 vaccines or mRNA vaccines (Li et al., 2020; Poh et al., 2020; Fraley et al., 2021; Ma et al., 2021).